NICE says cash back scheme 'not standard'

The NHS 'cash back' scheme for bortexomib (Velcade) approved by NICE last week, is unlikely to become the norm, say experts.

For the first time, NICE approved NHS use of a drug under a response–rebate scheme.

This means that if a patient shows no response to the drug, the manufacturer has to refund its cost to the NHS.

But NICE said the scheme was only considered after being suggested by manufacturer Janssen-Cilag.

If response–rebate is to be considered in the future it would have to be suggested by manufacturers and be approved in principle by the DoH.

A NICE spokesman said: ‘There are a number of factors that might need to be considered, such as whether it would be clinically appropriate for continuation of treatment to be determined on the basis of an appropriate response measure and how well the response measure predicts actual health outcomes.’

rachel.liddle@haymarket.com

More information about bortexomib on the NICE website.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

BMA House entrance

GPs face pension tax penalties worth 'half their post-tax income'

Rapid swings in inflation could leave GPs facing pension tax penalties worth 'half...

Sign outside BMA House

BMA to demand significant pay rises to combat 15 years of real-term cuts

The BMA is set to demand significant pay rises for all doctors to undo over a decade...

UK police station

Reporting a crime in the practice – the confidentiality dilemma

With incidents of aggressive behaviour from patients on the rise, Dr Emma Green,...

Sign reading 'General Medical Council'

GMC backs reversal of GP suspension over laptop and admits tribunal error

The GMC has admitted a medical tribunal was wrong to suspend a Manchester GP for...

Dr Chaand Nagpaul

Government 'willfully shrinking workforce' and exploiting doctors' goodwill, warns Nagpaul

The government is exploiting doctors' goodwill while persistently failing to adopt...

Vaccination tracker

UK COVID-19 vaccination programme tracker

GPs across the UK have led the largest-ever NHS vaccination programme in response...